| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |